Male factor infertility contributes to approximately forty to fifty percent of infertility cases, yet receives substantially less research attention and treatment innovation than female infertility, with the Fertility Services Market reflecting the growing recognition of male infertility as an equally important clinical and commercial focus alongside the female-centered services that have historically dominated fertility clinic offerings.

Semen analysis — the cornerstone of male infertility evaluation — assesses sperm concentration, motility, morphology, and volume according to WHO reference ranges, but conventional semen analysis parameters provide incomplete prediction of fertilization capacity for individual sperm samples. Advanced sperm function testing including DNA fragmentation assays, reactive oxygen species measurement, and hyaluronan binding assays provide additional diagnostic information for men with normal conventional semen parameters and unexplained infertility or recurrent IVF failure.

Surgical sperm retrieval — percutaneous epididymal sperm aspiration, testicular sperm aspiration, and micro-TESE microsurgical testicular sperm extraction — enables sperm recovery from men with azoospermia who would previously have had no prospect of biological fatherhood. Micro-TESE achieving sperm recovery rates of forty to sixty percent in non-obstructive azoospermia patients, combined with ICSI enabling fertilization with a single retrieved sperm, has transformed the prognosis for previously untreatable male infertility.

Genetic evaluation of azoospermic men — karyotype analysis detecting chromosomal abnormalities, Y chromosome microdeletion testing, and CFTR mutation screening — provides both diagnostic information explaining azoospermia etiology and prognostic information predicting surgical sperm retrieval success that guides treatment decisions and genetic counseling for offspring transmission risk.

Do you think non-invasive sperm DNA fragmentation testing will become routine in male infertility evaluation before IVF, replacing the selective use for recurrent failure that current clinical practice restricts it to?

FAQ

What causes male infertility? Male infertility causes include varicocele, hormonal disorders, genetic abnormalities including Y chromosome deletions and Klinefelter syndrome, infections, medications, and environmental toxin exposure affecting sperm production and function.

What is ICSI and when is it used? Intracytoplasmic sperm injection injects a single sperm directly into each egg, overcoming sperm count, motility, and morphology limitations that prevent conventional IVF fertilization; it is used for severe male factor infertility and other fertilization challenges.

What is micro-TESE for azoospermia? Microsurgical testicular sperm extraction uses operative microscopy to identify sperm-producing tubules in the testes of azoospermic men, achieving sperm recovery in forty to sixty percent of non-obstructive azoospermia cases for use in ICSI.

#FertilityServices #MaleInfertility #SpermRetrieval #Azoospermia #MaleFactorInfertility #ICSItreatment